TNX102 SL A Promising Treatment for PTSD and Sleep Disorders
Tonix Pharmaceuticals has recently released findings from a study showcasing the effectiveness of bedtime TNX-102 SL in enhancing symptoms of ...
© 2024 Stocks Today
Tag: TNXP
Revolutionizing Fibromyalgia Treatment Tonix Pharmaceuticals and EVERSANA Partner to Launch Tonmya
Tonix Pharmaceuticals has partnered with EVERSANA to develop a comprehensive launch strategy and commercialization plan for Tonmya, a promising treatment ...
Tonix Pharmaceuticals Hosts Webinar on Groundbreaking Fibromyalgia Treatment
On February 14, 2024, Tonix Pharmaceuticals Holding Corp., a renowned biopharmaceutical company, hosted a webinar featuring key opinion leaders (KOLs) ...
Tonix Pharmaceuticals Receives FDA Clearance for Phase 2 OASIS Trial of TNX102 SL for Acute Stress Disorders
On February 12, 2024, Tonix Pharmaceuticals received clearance from the FDA for its Investigational New Drug (IND) application regarding the ...
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Office Real Estate Investment Trusts REITs WellPositioned for ReturntoWork Trend